JavaScript is disabled.
Some features may not work properly. For the best experience, please enable JavaScript in your browser.
Ledgeburg
Sign In
Loading...
News
Latest
Latest News
Stocks
Discover
Search Stocks
ETFs
Discover
Search ETFs
Funds
Discover
Search Funds
TSHA Financials - Taysha Gene Therapies Income & Cash Flow | Ledgeburg
TSHA - Taysha Gene Therapies, Inc.
USD | NASDAQ | Healthcare
Summary
Summary TSHA Stock
Financials
Financials TSHA Stock
Loading...
Loading...
Income Statement
Income Statement TSHA Stock
Balance Sheet
Balance Sheet TSHA Stock
Cash Flow Statement
Cash Flow Statement TSHA Stock
Loading...
Loading...
Home
Stocks
Taysha Gene Therapies, Inc. (TSHA)
Financials
Financials of TSHA
Loading...
Loading...
Loading...
Loading...
Revenue
$9.773M
Operating Income
$-110.498M
Net Income
$-108.995M
Share Count (Basic)
319.711972M
Operating Cash Flow
$-93.09M
Free Cash Flow
$-93.828M
Cash And Short-Term Equivalents
$319.767M
Total Debt
$50.106M
Annual
Quarterly
Revenue $USD
0
5M
10M
15M
FY2022
FY2023
FY2024
FY2025
Revenue $USD
0
1M
2M
3M
4M
5M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Annual
Quarterly
Net Income $USD
-180M
-160M
-140M
-120M
-100M
-80M
Annual
Quarterly
Margins
Gross
Operating
Net
-6000%
-4000%
-2000%
0%
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Net Income $USD
-40M
-35M
-30M
-25M
-20M
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26
FY2021
FY2022
FY2023
FY2024
FY2025
Margins
Gross
Operating
Net
-1400%
-1200%
-1000%
-800%
-600%
Q1 FY25
Q2 FY25
Q3 FY25
Q4 FY25
Q1 FY26